Women’s Health Report Assesses first-in-class innovation with focus on endometriosis, polycystic ovarian syndrome and cervical intraepithelial neoplasia

This report assesses first-in-class innovation across the women’s health therapy area, with a particular focus on three key indications: endometriosis, polycystic ovarian syndrome (PCOS) and cervical intraepithelial neoplasia (CIN).

Pune, India - March 14, 2018 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population. Despite this, the women’s health market is relatively small. This reflects diagnostic barriers and high levels of non-treatment for women’s health disorders, as well as high levels of genericization and relatively limited innovation within recent decades.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline
Scope
• Many women’s health disorders are highly prevalent. How do epidemiology trends vary for endometriosis, PCOS and CIN?
• Innovation within women’s health has been relatively limited over recent decades. What are the most prominent unmet needs across this therapy area?
• There are 261 pipeline programs in active development for women’s health. What proportion of these products are first-in-class? How does first-in-class innovation vary by indication, development stage and molecular target class?
• Although the first-in-class pipeline is relatively modest in size it is considerably diverse with eight distinct molecular target classes represented. Which first-in-class targets have been identified as most promising for women’s health conditions?
• Over 200 licensing deals relating to women’s health have been completed since 2006. Do women’s health products typically attract high deal values? Which first-in-class products have prior deal involvement?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/987871
Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of symptoms, epidemiology, etiology, pathophysiology, co-morbidities and complications, diagnosis and treatment options.
• Visualize the composition of the women’s health market in terms of dominant molecule types and molecular targets, highlighting what the current unmet needs are and how they can be addressed. This knowledge allows a competitive understanding of gaps in the current market.
• Analyze the women’s health pipeline and stratify by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising first-in-class targets have been reviewed in greater detail.
• Recognize commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals, and identifying women’s health therapies that have not yet been involved in deals and may offer potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/987871

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/womens-health-report-assesses-first-in-class-innovation-with-focus-on-endometriosis-polycystic-ovarian-syndrome-and-cervical-intraepithelial-neoplasia/314337

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline%20%20

Source: MarketersMedia

Release ID: 314337

Latest News

Big Five? Talent-rich Celtics embracing lofty expectations

Sep 25, 2018

CANTON, Mass. — Last summer, new Boston Celtics arrivals Kyrie Irving and Gordon Hayward beamed just imagining what it would be like to share the court together. Those dreams lasted all of five minutes before Hayward was lost for the season to a gruesome leg injury on the opening night of the season. The Celtics somehow survived it and had set themselves up to make a run at the Eastern Conference title when Irving was lost for the final stretch of the regular season and the playoffs following a pair of knee surgeries. But four months after a season with...

No LeBron, no spotlight: Cavaliers start anew without star

Sep 25, 2018

INDEPENDENCE, Ohio — As the Cavaliers wandered around posing for silly photographs, reading radio promotions and doing interviews, everything felt different. This media day was nothing like the past four. Cleveland heads into the season with very little buzz, zero drama and low expectations. The spotlight, which has illuminated the Cavs in recent years, is pointed elsewhere. LeBron James left and it all went with him. "I'm still here," coach Tyronn Lue said, laughing. The Cavs began life without James in earnest on Monday, taking their first steps since the superstar signed with the Los Angeles Lakers this summer and...

With new coach and new arena, Giannis, Bucks are all smiles

Sep 25, 2018

MILWAUKEE — Giannis Antetokounmpo was all smiles but had no jokes. The Milwaukee Bucks' All-Star forward was more business this time around: While he didn't indulge reporters by opening his media day session on Monday with a gag, as he had done in previous years, Antetokounmpo still flashed an infectious grin. Things are looking up for the Milwaukee Bucks as they move into a new arena this fall, with a new coach leading a team headlined by one of the NBA's bright, young stars. The organization once had billboards around the city that read "Own the Future." That future is...

The Latest: Cosby lawyer argues to keep him out of prison

Sep 25, 2018

NORRISTOWN, Pa. — The Latest on Bill Cosby's sentencing hearing (all times local): 3:45 p.m. Bill Cosby's lawyer says the 81-year-old comedian is a poor candidate for prison because he's old, legally blind and dependent on others. Defense lawyer Joseph Green argued at Cosby's sentencing hearing Monday that Cosby would be at risk behind bars. He called prison an "excessive hardship." Green suggested an alternative punishment program would be more appropriate. Court has adjourned for the day. A judge is expected to sentence Cosby on Tuesday. Cosby's lawyer says a psychologist set to testify Tuesday will be the only defense...

Porzingis rehabbing conservatively, unsure when he'll return

Sep 25, 2018

GREENBURGH, N.Y. — Kristaps Porzingis is a one-of-a-kind player, a 7-foot-3 package strong enough to pound in the paint but with plenty of speed and shooting to play on the perimeter. That's ideal for the basketball court. Not so much for rehabbing a serious knee injury. Porzingis said Monday his size has necessitated a slow recovery from a torn left ACL and prevents him or the New York Knicks from establishing a timetable for his return to action. "We've done things differently because there is no protocol for a 7-3 guy," Porzingis said. "There is no timetable for my type...

About Us

The Final Scoreboard has fast, accurate live scores for you. We provide premium online content from in-depth analysis to the scores and statistics across American and European Sports.

Contact us: sales[at]thefinalscoreboard.com

Subscribe Now!